Molnupiravir, an investigational oral antiviral drug discovered by Emory researchers, appears to significantly reduce the risk of hospitalization or death in patients with mild to moderate COVID-19, according to interim data from a Phase 3 study.
Recent News Releases »
Faculty Opinion »
Opinion: COVID has made getting into a top U.S. college even more competitive and this new normal looks here to stay
Featured Expert »
Political scientist Andra Gillespie specializes in political mobilization and race and is the author of "The New Black Politician: Cory Booker, Newark and Post-Racial America."
How customized antibiotic combinations could defeat 'superbugs'
A sneaky form of antibiotic resistance called "heteroresistance" is more widespread than previously appreciated. But tracking heteroresistance might guide the choice of antibiotic combinations that can defeat bacteria regarded as invincible.
Emory in the News »
WABE-FM, Oct. 21
NBC News, Oct. 20
Atlanta Magazine, Oct. 19
New York Times, Oct. 14
- Emory Healthcare CEO Jonathan Lewin in a joint CNN column with Delta CEO Ed Bastian